4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
SIGA Technologies, Inc. (SIGA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in New York, United States with about 49 employees. Its market capitalization is roughly $232 million. In the fiscal year ended 2025-12-31, SIGA reported $95M in revenue and $23M in net income.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc.
Interactive charts & full statements → Open the SIGA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $95M | $139M | $140M | $111M | — |
| Gross Profit | $65M | $107M | $122M | $100M | — |
| Operating Income (EBIT) | $24M | $70M | $84M | $43M | — |
| Net Income | $23M | $59M | $68M | $34M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $41M | $6M | $4M | $3M | $81M | — |
| Gross Profit | $23M | $3M | $1M | $2M | $56M | — |
| Operating Income (EBIT) | $14M | ($5M) | ($10M) | ($10M) | $46M | — |
| Net Income | $12M | ($4M) | ($5M) | ($6M) | $36M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | ($43M) | ($43M) | ($32M) | ($33M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Dividends Paid | ($43M) | ($0M) | ($0M) | ($0M) | ($43M) | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $220M | $244M | $254M | $195M | — |
| Total Liabilities | $21M | $28M | $58M | $25M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SIGA viewer.
About TickerBase · Data methodology & sources · Privacy · Terms